title: MyoRing treatment of myopia.
abstract: BACKGROUND
  Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life.
  
  
  METHODS
  19 myopic eyes of 12 patients ranging from -2.25 to -16.5 dioptres (D) in sphere and from 0 to -4D in cylinder were analyzed.
  
  
  RESULTS
  After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from -10.27D to -0.93D. Efficacy index was 0.76 and safety index was 1.02.
  
  
  CONCLUSIONS
  MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important.
authors.affiliation: GutSehen Eye Center, Ybbs, Austria; Department of Ophthalmolgy, Medical University of Innsbruck, Austria. Electronic address: daxer@gutsehen.at.
authors.forename: Albert
authors.initials: A
authors.lastname: Daxer
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D054018:Lasers, Excimer / Q000627:therapeutic use*; D019654:Lens Implantation, Intraocular / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000503:physiopathology / Q000601:surgery*; D011474:Prosthesis Design; D012029:Refraction, Ocular / Q000502:physiology*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
keywords: CISIS; Corrección de la visión con láser; LASIK; LIO fáquicas; Miopía; MyoRing; Myopia; Phakic IOL